Michael W Colvin

US Patent:

7099718, Aug 29, 2006

Filed:

May 24, 2002

Appl. No.:

10/155146

Inventors:

James R. Thacker - Eureka MO, US
David K. L. Peterson - Saugus CA, US
James P. McGivern - Stevenson Ranch CA, US
Michael S. Colvin - Malibu CA, US

Assignee:

Advanced Bionics Corporation - Valencia CA

International Classification:

A61N 1/05

US Classification:

607117

Abstract:

An implantable lead having at least one electrode contact at or near its distal end prevents undesirable movement of the electrode contact from its initial implant location. One embodiment relates to a spinal cord stimulation (SCS) lead. A balloon may be positioned on the electrode lead array. The balloon is filled with air, liquid or a compliant material. When inflated, the balloon stabilizes the lead with respect to the spinal cord and holds the lead in place. The pressure of the balloon is monitored or otherwise controlled during the filling process in order to determine at what point the filling process should be discontinued. An elastic aspect of the balloon serves as a contained relief valve to limit the pressure the balloon may place on the surrounding tissues when the epidural space is constrained.

US Patent:

7856277, Dec 21, 2010

Filed:

Aug 11, 2006

Appl. No.:

11/464137

Inventors:

James R. Thacker - Eureka MO, US
Michael S Colvin - Newbury Park CA, US
David K. L. Peterson - Saugus CA, US
James P. McGivern - Wake Forest NC, US

Assignee:

Boston Scientific Neuromodulation Corporation - Valencia CA

International Classification:

A61N 1/372

US Classification:

607117

Abstract:

An implantable lead having at least one electrode contact at or near its distal end prevents undesirable movement of the electrode contact from its initial implant location. One embodiment relates to a spinal cord stimulation (SCS) lead. A first injectable material is injected into the dura space to mechanically position the electrode array with respect to the spinal cord. Conjunctively for use with adhesives, or alternatively for use instead of the adhesives, a balloon may be positioned on the electrode lead array. The balloon is filled with air, liquid or a compliant material. When inflated, the balloon stabilizes the lead with respect to the spinal cord and holds the lead in place. An elastic aspect of the balloon serves as a contained relief valve to limit the pressure the balloon may place on the surrounding tissues when the epidural space is constrained.

US Patent:

7983766, Jul 19, 2011

Filed:

Aug 11, 2006

Appl. No.:

11/464128

Inventors:

James R. Thacker - Eureka MO, US
Michael S Colvin - Newbury Park CA, US
David K. L. Peterson - Saugus CA, US
James P. McGivern - Wake Forest NC, US

Assignee:

Boston Scientific Neuromodulation Corporation - Valencia CA

International Classification:

A61N 1/00

US Classification:

607117

Abstract:

An implantable lead having at least one electrode contact at or near its distal end prevents undesirable movement of the electrode contact from its initial implant location. One embodiment relates to a spinal cord stimulation (SCS) lead. A first injectable material is injected into the dura space to mechanically position the electrode array with respect to the spinal cord. Conjunctively for use with adhesives, or alternatively for use instead of the adhesives, a balloon may be positioned on the electrode lead array. The balloon is filled with air, liquid or a compliant material. When inflated, the balloon stabilizes the lead with respect to the spinal cord and holds the lead in place. An elastic aspect of the balloon serves as an internal contained relief valve to limit the pressure the balloon may place on the surrounding tissues when the epidural space is constrained.

US Patent:

8295945, Oct 23, 2012

Filed:

Aug 11, 2006

Appl. No.:

11/464109

Inventors:

James R. Thacker - Eureka MO, US
Michael S Colvin - Newbury Park CA, US
David K. L. Peterson - Saugus CA, US
James P. McGivern - Wake Forest NC, US

Assignee:

Boston Scientific Neuromodulation Corporation - Valencia CA

International Classification:

A61N 1/05

US Classification:

607117, 607118

Abstract:

An implantable lead having at least one electrode contact at or near its distal end prevents undesirable movement of the electrode contact from its initial implant location. One embodiment relates to a spinal cord stimulation (SCS) lead. A first injectable material is injected into the dura space to mechanically position the electrode array with respect to the spinal cord. Conjunctively for use with adhesives, or alternatively for use instead of the adhesives, a balloon may be positioned on the electrode lead array. The balloon is filled with air, liquid or a compliant material. When inflated, the balloon stabilizes the lead with respect to the spinal cord and holds the lead in place. An elastic aspect of the balloon serves as an internal contained relief valve to limit the pressure the balloon may place on the surrounding tissues when the epidural space is constrained.

US Patent:

8554342, Oct 8, 2013

Filed:

Sep 14, 2012

Appl. No.:

13/620138

Inventors:

James R. Thacker - Eureka MO, US
Michael S. Colvin - Newbury Park CA, US
David K. L. Peterson - Saugus CA, US
James P. McGivern - Wake Forest NC, US

Assignee:

Boston Scientific Neuromodulation Corporation - Valencia CA

International Classification:

A61N 1/05

US Classification:

607117, 607116, 607129, 607130, 607126

Abstract:

An implantable lead having at least one electrode contact at or near its distal end prevents undesirable movement of the electrode contact from its initial implant location. One embodiment relates to a spinal cord stimulation (SCS) lead. A first injectable material is injected into the dura space to mechanically position the electrode array with respect to the spinal cord. Conjunctively for use with adhesives, or alternatively for use instead of the adhesives, a balloon may be positioned on the electrode lead array. The balloon is filled with air, liquid or a compliant material. When inflated, the balloon stabilizes the lead with respect to the spinal cord and holds the lead in place. An elastic aspect of the balloon serves as an internal contained relief valve to limit the pressure the balloon may place on the surrounding tissues when the epidural space is constrained.

US Patent:

20220257956, Aug 18, 2022

Filed:

May 9, 2022

Appl. No.:

17/739748

Inventors:

- Brooklyn Park MN, US
Kenneth Lyle Reed - Dallas TX, US
Robert Raymond Bulger - Dallas TX, US
Claire Denault - Dallas TX, US
Michael Steven Colvin - Newbury Park CA, US
Paul Griffith - Brooklyn Park MN, US
Francis Menezes - Simi Valley CA, US

International Classification:

A61N 1/378
A61N 1/372
A61N 1/05
A61N 1/375
A61N 1/36

Abstract:

A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.

US Patent:

20210046319, Feb 18, 2021

Filed:

Oct 30, 2020

Appl. No.:

17/085434

Inventors:

- Santa Clara CA, US
Robert Raymond Bulger - Dallas TX, US
Michael Steven Colvin - Newbury Park CA, US
Claire Denault - Dallas TX, US

International Classification:

A61N 1/378
A61N 1/372
A61N 1/05
A61N 1/375
A61N 1/36

Abstract:

A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.

US Patent:

20200289833, Sep 17, 2020

Filed:

May 29, 2020

Appl. No.:

16/887498

Inventors:

- Santa Clara CA, US
Kenneth Lyle Reed - Dallas TX, US
Robert Raymond Bulger - Dallas TX, US
Claire Denault - Dallas TX, US
Michael Steven Colvin - Newbury Park CA, US
Paul Griffith - Santa Rosa Valley CA, US
Francis Menezes - Simi Valley CA, US

International Classification:

A61N 1/378
A61N 1/372
A61N 1/05
A61N 1/375
A61N 1/36

Abstract:

A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.